CA3177704A1 - Stem cells for treatment of respiratory disorders - Google Patents

Stem cells for treatment of respiratory disorders Download PDF

Info

Publication number
CA3177704A1
CA3177704A1 CA3177704A CA3177704A CA3177704A1 CA 3177704 A1 CA3177704 A1 CA 3177704A1 CA 3177704 A CA3177704 A CA 3177704A CA 3177704 A CA3177704 A CA 3177704A CA 3177704 A1 CA3177704 A1 CA 3177704A1
Authority
CA
Canada
Prior art keywords
composition
mscs
use according
disease
integrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3177704A
Other languages
English (en)
French (fr)
Inventor
Evy Lundgren Akerlund
Sandra LINDSTEDT
Christina UVEBRANT
Tania RAMOS MORENO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xintela AB
Original Assignee
Xintela AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xintela AB filed Critical Xintela AB
Publication of CA3177704A1 publication Critical patent/CA3177704A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplantation (AREA)
CA3177704A 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders Pending CA3177704A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20173592 2020-05-07
EP20173592.5 2020-05-07
PCT/EP2021/062111 WO2021224449A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Publications (1)

Publication Number Publication Date
CA3177704A1 true CA3177704A1 (en) 2021-11-11

Family

ID=70738255

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3177704A Pending CA3177704A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Country Status (11)

Country Link
US (1) US20230346843A1 (https=)
EP (1) EP4146234A1 (https=)
JP (1) JP7821414B2 (https=)
KR (1) KR20230008159A (https=)
CN (1) CN116018149A (https=)
AU (1) AU2021266603A1 (https=)
BR (1) BR112022022355A2 (https=)
CA (1) CA3177704A1 (https=)
IL (1) IL297902A (https=)
MX (1) MX2022013939A (https=)
WO (1) WO2021224449A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202103890D0 (en) * 2021-03-19 2021-05-05 Amniotics Ab Stem cells for use in reducing the immune response following organ transplantation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007099337A1 (en) * 2006-03-01 2007-09-07 Cartela R&D Ab Expansion and differentiation of mesenchymal stem cells
CN110177560A (zh) * 2016-12-28 2019-08-27 智再如股份有限公司 活体组织损伤的修复剂以及该修复剂的制造方法
ES2870776T3 (es) 2017-01-27 2021-10-27 Xintela Ab Prevención y tratamiento de daños o enfermedades de los huesos y cartílagos
CN116590227A (zh) * 2017-03-03 2023-08-15 日本乐敦制药株式会社 间充质干细胞和肝疾病治疗剂
WO2018159432A1 (ja) * 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物

Also Published As

Publication number Publication date
CN116018149A (zh) 2023-04-25
BR112022022355A2 (pt) 2022-12-13
JP2023524150A (ja) 2023-06-08
MX2022013939A (es) 2023-02-09
US20230346843A1 (en) 2023-11-02
JP7821414B2 (ja) 2026-02-27
EP4146234A1 (en) 2023-03-15
KR20230008159A (ko) 2023-01-13
WO2021224449A1 (en) 2021-11-11
AU2021266603A1 (en) 2022-12-08
IL297902A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
Lu et al. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury
JP7691488B2 (ja) 肺疾患を治療するための方法及び組成物
CN106714781B (zh) 涉及外排体的方法和组合物
Chou et al. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
Zhu et al. Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury
JP6666395B2 (ja) 移植のための臓器の改良
EP3443966A1 (en) Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
US20160287642A1 (en) Methods of treating or preventing a lung disorder
KR102464099B1 (ko) 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료
Chaleshtori et al. Prevention of LPS-induced acute respiratory distress syndrome in sheep by bone marrow-derived mesenchymal stem/stromal cells
US20230346843A1 (en) Stem Cells for Treatment of Respiratory Disorders
Siavashi et al. The improvement of respiratory performance after phototherapy‐induced EPC mobilization in preterm infants with RDS
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
US20200054684A1 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
CN117425724A (zh) 肿瘤缺氧驯化的再生巨噬细胞的获得方法及其在再生医学中的用途
US20230338432A1 (en) Methods and compositions for treating viral infections and sequelae thereof
Tran et al. The synergistic effects of mechanical ventilation and intrauterine inflammation on cerebral inflammation in preterm fetal sheep
Wu et al. Wnt3a Enhances Mesenchymal Stem Cell Engraftment and Differentiation in a Chronic Obstructive Pulmonary Disease Rat Model
US20180353549A1 (en) Compositions and method for treating and preventing bleeding and lung injuries and diseases
WO2021207192A1 (en) Methods and compositions for allergy and asthma treatment using fibroblasts
Curley Investigation of the mechanisms of repair following Ventilator Induced Lung Injury and the potential for Mesenchymal Stem Cells to enhance the repair process
Moawed et al. Assessment of cord blood vascular endothelial growth factor levels and circulating CD34+ cells in preterm infants with respiratory distress syndrome
Spaziano et al. Research Article New Role of Adult Lung c-kit Cells in a Mouse Model of Airway Hyperresponsiveness
Haaften Mesenchymal stem cells protect the lung from oxygen-induced experimental bronchopulmonary dysplasia

Legal Events

Date Code Title Description
MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD

Year of fee payment: 4

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250414

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250414

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED

Effective date: 20250430

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT

Effective date: 20250430

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250430

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250505

D00 Search and/or examination requested or commenced

Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT

Effective date: 20250714

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT

Effective date: 20250714

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED

Effective date: 20250714

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20250714

D11 Substantive examination requested

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT

Effective date: 20260309

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260414

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260414